[
  {
    "ingredient1": "paracetamol",
    "ingredient2": "warfarin",
    "severity": "major",
    "type": "pharmacodynamic",
    "effect": "Increased risk of bleeding",
    "arabic_effect": "زيادة خطر النزيف",
    "recommendation": "Monitor INR closely",
    "arabic_recommendation": "يجب مراقبة سيولة الدم (INR) بدقة"
  },
  {
    "ingredient1": "aspirin",
    "ingredient2": "warfarin",
    "severity": "severe",
    "type": "pharmacodynamic",
    "effect": "Significantly increased risk of bleeding",
    "arabic_effect": "خطر كبير جداً للنزيف",
    "recommendation": "Avoid combination if possible",
    "arabic_recommendation": "تجنب الجمع بينهما قدر الإمكان"
  },
  {
    "ingredient1": "ibuprofen",
    "ingredient2": "aspirin",
    "severity": "moderate",
    "type": "pharmacodynamic",
    "effect": "Reduced cardioprotective effect of aspirin",
    "arabic_effect": "تقليل تأثير الأسبرين الحامي للقلب",
    "recommendation": "Take ibuprofen 30 mins after or 8 hours before aspirin",
    "arabic_recommendation": "تناول الإيبوبروفين بعد 30 دقيقة أو قبل 8 ساعات من الأسبرين"
  },
  {
    "ingredient1": "sildenafil",
    "ingredient2": "nitroglycerin",
    "severity": "contraindicated",
    "type": "pharmacodynamic",
    "effect": "Severe hypotension (low blood pressure)",
    "arabic_effect": "انخفاض حاد وخطير في ضغط الدم",
    "recommendation": "Do not use together",
    "arabic_recommendation": "ممنوع الاستخدام معاً نهائياً"
  },
  {
    "ingredient1": "simvastatin",
    "ingredient2": "clarithromycin",
    "severity": "major",
    "type": "pharmacokinetic",
    "effect": "Increased risk of myopathy/rhabdomyolysis",
    "arabic_effect": "زيادة خطر تحلل العضلات",
    "recommendation": "Avoid combination or suspend simvastatin",
    "arabic_recommendation": "تجنب الجمع أو أوقف السيمفاستاتين مؤقتاً"
  }
]